Oncology Early Phase / Multiple Disease Site Hematologic Malignancies Early Phase Team Leukemia MDS Relapsed/Refractory
Categories
Protocols
HMP-2020-306-GLOB1 Phase I OPEN TO ACCRUAL *
A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Hematological Malignancies with Isocitrate Dehydrogenase (IDH) Mutations